Castelli Jeff

Avg. Two Year Performance

15% Avg. Purchase Return
7% Compound
25% Avg. Sale Return
12% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)22%60%14%15%
Purchase Success Rate0 of 22 of 22 of 21 of 22 of 2
Average Sale Return(7%)(26%)1%34%25%
Sale Success Rate4 of 60 of 62 of 64 of 64 of 6

Amicus Therapeutics, Inc.

Drugs » Biotechnology

Chief Development Officer:

Holdings: 362.8K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--